Even during all the commotion surrounding IMM-124E’s potential re. Ash/Nash. IMM-529 and it’s efficacy on CDiff. was always showing greater potential
Whilst FDA approval of IMM-124E will pollster sales and allow its use against a wider range of medical conditions (some potentially for which it hasn’t even been tested against, as of yet). I still see a greater long term potential for IMM-529.
Hence why I continue to both acquire at these ridiculous lows and continue to hold.
IMC Price at posting:
13.5¢ Sentiment: Hold Disclosure: Held
